Intro

This chapter features a spirited competition among speakers to uncover the most significant business stories of the week, particularly focusing on the Australian-U.S. tensions regarding pharmaceutical policies. They humorously debate the implications of Australia's Pharmaceutical Benefits Scheme on drug pricing and international trade ties with U.S. companies, blending economic discourse with light-hearted rivalry.